Ella, Lubosan .

HRN: 28-68-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/10/2026
03/17/2026
IV
4.5g
Q8
CAP HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaCentral Nervous System    Compliance to guidelines: